Yangyang Qi
Building West 13, No. 138 Yixueyuan Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review.
Journal: Vaccines
Published: May 21, 2024
Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours.
Journal: Japanese journal of clinical oncology
Published: September 29, 2023
Erratum to "Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion" [Eur. Urol. 75(5) (2019) 752-763].
Journal: European urology
Published: September 25, 2023
Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Journal: Annals of surgery
Published: June 09, 2020
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2020
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2019
Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis.
Journal: British journal of cancer
Published: December 08, 2019
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: October 29, 2019
Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 31, 2019
Blockade of DC-SIGN+ Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder Cancer.
Journal: Cancer research
Published: July 22, 2019
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
Journal: International journal of cancer
Published: May 24, 2019
Last Updated: 09/26/2026